Skip to main content
Cancer Genomics & Proteomics logoLink to Cancer Genomics & Proteomics
. 2023 Sep 3;20(5):412–416. doi: 10.21873/cgp.20393

Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells

SACHIKO INUBUSHI 1,2,3, TOMONARI KUNIHISA 1, SACHIKO MIZUMOTO 1, SHOTARO INOUE 1, MAYUKO MIKI 1, ATSUSHI SUETSUGU 4, HIROKAZU TANINO 5, ROBERT M HOFFMAN 2,3
PMCID: PMC10464940  PMID: 37643781

Abstract

Background/Aim

Methionine addiction is the elevated requirement for exogenous methionine for growth and survival of cancer cells, termed the Hoffman effect. Methionine-addicted cancer cells synthesize normal or excess amounts of methionine but still need an external source of methionine. Methionine restriction (MR) by either a methionine-free medium or in vivo by a low-methionine diet or by methioninase, selectively arrests cancer cells in the late S/G2 cell cycle phase, but not normal cells. The present study focuses on the comparison of production and secretion of exosomes by cancer cells under MR and normal conditions.

Materials and Methods

MDA-MB-231 cells (triple-negative breast cancer), containing exosomes labeled with CD63-GFP (CD63-GFP exosomes), were visualized by fluorescence microscopy. MDA-MB-231 cells expressing exosome-specific CD63-GFP were cultured in methionine-containing (MET+) or in methionine-free (MET−) DMEM conditions. Exosomes were isolated by ultracentrifugation and characterized by nanoparticle tracking analysis (NTA) and Western blotting.

Results

When MDA-MB-231-CD63-GFP cells were cultured under MR conditions, they arrested their growth and CD63-GFP-expressing exosomes were strongly increased in the cells. MR resulted in approximately a 2-fold increase in exosome production and secretion per cell, even though cell growth was arrested. Methionine restriction, thus, resulted in elevated exosome production and secretion per surviving cell.

Conclusion

Exosome production and secretion in the cancer cells increased under MR, suggesting a relation between MR and exosome production and secretion.

Keywords: Exosomes, cancer cells, methionine addiction, breast cancer, CD63, GFP, methionine restriction


Exosomes are vesicles that vary in size between 30-150 nm. Exosomes originate from endosomal membranes (1) and are produced and secreted by cancer and other cells for intercellular communication and other purposes. Methionine addiction (2-12) is a universal and fundamental hallmark of cancer termed the Hoffman effect (2-17).

Methionine addiction is due to excess transmethylation reactions in cancer cells that results in much higher requirement for methionine for growth and survival than normal cells (3,4,6,7,14,15). Cancer cells selectively arrest in the S/G2 phases of the cell cycle after methionine restriction (16,17).

In the present study we aimed to determine the effect of methionine restriction (MR) on exosome production and secretion in cancer cells. For imaging of exosome production in cancer cells under normal and MR conditions we previously introduced the exosome marker CD63 linked to green fluorescent protein (GFP) (CD63-GFP) to the human triple-negative breast cancer cell line MDA-MB-231, with a lentivirus vector (18). In MDA-MB-231-CD63-GFP cells, exosomes are brightly seen with GFP fluorescence. Surprising and paradoxical results of the present study show MR of MDA-MB-231-CD63-GFP cells resulted in increased production and secretion of exosomes, compared to normal methionine conditions.

Materials and Methods

Cell line. The human breast cancer cell line, MDA-MB-231, was previously transformed to express the exosome-specific protein CD63 labeled with green fluorescent protein (CD63-GFP) (18).

The MDA-MB231-CD63-GFP cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) and 100 IU/ml penicillin/streptomycin and incubated at 37˚C in an atmosphere of 5% CO2 95% air. The cells were washed with phosphate-buffered saline (PBS), and the culture medium was replaced with DMEM medium with methionine (MET+) or without methionine (MET-) (19).

Preparation of conditioned medium and secreted exosomes. After incubation of MDA-MB-231-CD63-GFP cells for 24 h in MET+ or MET- medium, the conditioned medium (CM) was collected. Exosomes from the CM were isolated by an ultracentrifugation protocol, as reported previously (20). Briefly, the CM was centrifuged at 2,000 × g for 10 min to remove contaminating cells. The resulting supernatants were then transferred to fresh tubes and filtered through a 0.22-μm filter (Millipore). The filtered CM was centrifuged for 90 min at 110,000 × g to pellet the enriched exosomes (Beckman Coulter, Brea, CA, USA). The pellets were washed with PBS and ultracentrifuged at 110,000 × g for another 90 min.

Preparation of cell lysates. Whole-cell lysates were prepared with RIPA buffer (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan). After collection of the CM, the cells in culture dishes were washed with PBS and RIPA buffer. The cell lysates were measured for protein content using a Takara BCA protein assay kit (Takara, Bio Inc., Shiga, Japan).

Western blotting. Cell lysates were prepared for Western blotting as described previously (21). An anti-CD63 antibody was used to quantify intracellular exosomes (BD Biosciences, Franklin Lakes, NJ, USA).

Exosome particle size analysis. Exosome size, concentration and distribution were analyzed by nanoparticle tracking analysis (NTA) software using a NanoSight NS500 particle counter (Malvern Panalytical Ltd., Malvern, UK). The software was optimized to identify and track each exosome particle on a frame-by-frame basis and Brownian movement was tracked and measured from frame to frame (20).

Results

Growth of MDA-MB-231-CD63-GFP cells under methionine restriction. MDA-MB-231-CD63-GFP cells were seeded in normal medium, then the medium was replaced with normal or methionine-restricted (MR) medium. After 24 and 48 hours the number of cells in 6 fields of view under a fluorescence microscope was counted. MDA-MB-231-CD63-GFP cells significantly arrested their growth by 24 hours (p<0.05) under methionine restriction (MR) and by 48 hours under MR there was a very large difference in cell number between the 2 groups (p<0.0005) (Figure 1).

Figure 1. Methionine addiction of MDA-MB-231-CD63-GFP cells. Bar graphs showing the number of cells per microscopic field for MDA-MB-231-CD63-GFP cells at 24 and 48 h under methionine restriction and normal-methionine conditions.

Figure 1

Exosome production by MDA-MB-231-CD63-GFP cells under methionine restriction. MDA-MB-231-CD63 cells were cultured in normal or MR media and then observed for CD63-GFP fluorescence in the cells. MDA-MB-231-CD63-GFP showed more fluorescence under MR than under normal conditions, suggesting greater production of exosomes under MR (Figure 2). Six fields of view were analyzed for the degree of GFP brightness using a Keyence BZ-X800 fluorescence analyzer. CD63-GFP fluorescence per cell was significantly higher under MR than normal conditions and at 48 hours with a very large increase of fluorescence under MR (p<0.005) (Figure 3).

Figure 2. Fluorescence imaging of CD63-GFP exosomes in MDA-MB-231-CD63-GFP cells under methionine restriction and normal-methionine conditions.

Figure 2

Figure 3. CD63-GFP exosome fluorescence per MDA-MB-231-CD63-GFP cell under methionine restriction and normal conditions.

Figure 3

Production of CD63 by MDA-MB-231-CD63-GFP cells under methionine restriction. Western blotting of cell lysates showed CD63 production increased in MDA-MB-231-CD63-GFP cells under MR (Figure 4). Thus, the production of exosomes was strongly elevated in MDA-MB-231-CD63-GFP cells under MR.

Figure 4. Western blotting of CD63-GFP expression in MDA-MB-231-CD63-GFP cells under methionine restriction and normal conditions.

Figure 4

Secretion of exosomes by MDA-MB-231 cells under methionine restriction. In order to count the number of exosomes excreted in the medium of MDA-MB-231 cells under normal and MR conditions, exosomes were isolated by ultracentrifugation using conditioned medium collected 24 h after exposure to MR or control conditions. The ultracentrifuged exosomes were quantified by NTA counting of secreted exosome particles which showed that the exosomes particle number per cell increased under MR for 24 hours (p<0.05) (Figure 5). The exosome size was similar under MR and normal conditions (Figure 6).

Figure 5. Exosome secretion by MDA-MB-231 cells under methionine restriction [MET(-)] and normal conditions [MET(+)], as measured by a NanoSight NS500 particle counter.

Figure 5

Figure 6. Size of exosome particles secreted by MDA-MB-231 cells under methionine restriction [MET(-)] and normal conditions [MET(+)], as measured by a NanoSight NS500 particle counter.

Figure 6

Discussion

Methionine addiction of cancer cells was discovered by one of our team (2) and is now termed the Hoffman effect (22). Cancer cells were previously found to be methionine dependent, unlike normal cells which could grow when methionine was replaced by homocysteine (23,24). It was initially thought that cancer cell could not make methionine from homocysteine (24,25) but later it was found that cancer cells make large amount of methionine from homocysteine (2,3,26). It was thus paradoxical when we showed cancer cells made more methionine from homocysteine than normal cells, but still needed external methionine for growth and survival, with the external methionine possibly used by cancer cells for excess transmethylation reactions (3-7,14,15,27). These results demonstrated methionine addiction in cancer cells (2,3).

The present results were also surprising and paradoxical that under MR the MDA-MB231-CD63-GFP cells arrested their growth but produced and secreted much more exosomes. Why the cancer cell should expend resources on exosome production and secretion under MR where they are not able to grow and are dying is an important question and suggests a relationship between exosome production, secretion, and MR. Our current hypothesis is that the increase in exosomes production by cancer cells under MR is a stress response, Increased production of exosomes may serve as a biomarker of methionine starvation by cancer cells which may have clinical application for MR therapy (28) since exosomes can be measured in the body fluids such as tears (21). Future preclinical and clinical research is necessary.

Conflicts of Interest

The Authors declare no conflicts of interest.

Authors’ Contributions

Conception and design: SI, and RMH. Performed the experiments: SI. Interpretation: TK, SM, SIn, MM, AS and HT. Manuscript writing: SI and RMH. Approval of manuscript: All Authors.

Acknowledgements

This work was supported by PI Training Program for International Collaborative Research, Kobe University, 2021 and JSPS KAKENHI.

References

  • 1.Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi: 10.1038/ncb1596. [DOI] [PubMed] [Google Scholar]
  • 2.Hoffman RM, Erbe RW. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci USA. 1976;73(5):1523–1527. doi: 10.1073/pnas.73.5.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wang Z, Yip LY, Lee JHJ, Wu Z, Chew HY, Chong PKW, Teo CC, Ang HY, Peh KLE, Yuan J, Ma S, Choo LSK, Basri N, Jiang X, Yu Q, Hillmer AM, Lim WT, Lim TKH, Takano A, Tan EH, Tan DSW, Ho YS, Lim B, Tam WL. Methionine is a metabolic dependency of tumor-initiating cells. Nat Med. 2019;25(5):825–837. doi: 10.1038/s41591-019-0423-5. [DOI] [PubMed] [Google Scholar]
  • 4.Yamamoto J, Han Q, Inubushi S, Sugisawa N, Hamada K, Nishino H, Miyake K, Kumamoto T, Matsuyama R, Bouvet M, Endo I, Hoffman RM. Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells. Biochem Biophys Res Commun. 2020;533(4):1034–1038. doi: 10.1016/j.bbrc.2020.09.108. [DOI] [PubMed] [Google Scholar]
  • 5.Yamamoto J, Aoki Y, Han Q, Sugisawa N, Sun Y, Hamada K, Nishino H, Inubushi S, Miyake K, Matsuyama R, Bouvet M, Endo I, Hoffman RM. Reversion from methionine addiction to methionine independence results in loss of tumorigenic potential of highly-malignant lung-cancer cells. Anticancer Res. 2021;41(2):641–643. doi: 10.21873/anticanres.14815. [DOI] [PubMed] [Google Scholar]
  • 6.Yamamoto J, Aoki Y, Inubushi S, Han Q, Hamada K, Tashiro Y, Miyake K, Matsuyama R, Bouvet M, Clarke SG, Endo I, Hoffman RM. Extent and instability of trimethylation of histone H3 lysine increases with degree of malignancy and methionine addiction. Cancer Genomics Proteomics. 2022;19(1):12–18. doi: 10.21873/cgp.20299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Aoki Y, Han Q, Tome Y, Yamamoto J, Kubota Y, Masaki N, Obara K, Hamada K, Wang JD, Inubushi S, Bouvet M, Clarke SG, Nishida K, Hoffman RM. Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation. Front Oncol. 2022;12:1009548. doi: 10.3389/fonc.2022.1009548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hoffman RM, Jacobsen SJ, Erbe RW. Reversion to methionine independence in simian virus 40-transformed human and malignant rat fibroblasts is associated with altered ploidy and altered properties of transformation. Proc Natl Acad Sci USA. 1979;76(3):1313–1317. doi: 10.1073/pnas.76.3.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hoffman RM, Jacobsen SJ, Erbe RW. Reversion to methionine independence by malignant rat and SV40-transformed human fibroblasts. Biochem Biophys Res Commun. 1978;82(1):228–234. doi: 10.1016/0006-291x(78)90600-9. [DOI] [PubMed] [Google Scholar]
  • 10.Kubota Y, Sato T, Hozumi C, Han Q, Aoki Y, Masaki N, Obara K, Tsunoda T, Hoffman RM. Superiority of [(11)C]methionine over [(18)F]deoxyglucose for PET Imaging of Multiple Cancer Types Due to the Methionine Addiction of Cancer. Int J Mol Sci. 2023;24(3):1935. doi: 10.3390/ijms24031935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Stern PH, Wallace CD, Hoffman RM. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol. 1984;119(1):29–34. doi: 10.1002/jcp.1041190106. [DOI] [PubMed] [Google Scholar]
  • 12.Hoffman RM, Coalson DW, Jacobsen SJ, Erbe RW. Folate polyglutamate and monoglutamate accumulation in normal and SV40-transformed human fibroblasts. J Cell Physiol. 1981;109(3):497–505. doi: 10.1002/jcp.1041090316. [DOI] [PubMed] [Google Scholar]
  • 13.Mecham JO, Rowitch D, Wallace C, Stern PH, Hoffman RM. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun. 1983;117(2):429–434. doi: 10.1016/0006-291x(83)91218-4. [DOI] [PubMed] [Google Scholar]
  • 14.Stern PH, Hoffman RM. Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro. 1984;20(8):663–670. doi: 10.1007/BF02619617. [DOI] [PubMed] [Google Scholar]
  • 15.Judde JG, Ellis M, Frost P. Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res. 1989;49(17):4859–4865. [PubMed] [Google Scholar]
  • 16.Hoffman RM, Jacobsen SJ. Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A. 1980;77(12):7306–7310. doi: 10.1073/pnas.77.12.7306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yano S, Li S, Han Q, Tan Y, Bouvet M, Fujiwara T, Hoffman RM. Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity. Oncotarget. 2014;5(18):8729–8736. doi: 10.18632/oncotarget.2369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Suetsugu A, Honma K, Saji S, Moriwaki H, Ochiya T, Hoffman RM. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv Drug Deliv Rev. 2013;65(3):383–390. doi: 10.1016/j.addr.2012.08.007. [DOI] [PubMed] [Google Scholar]
  • 19.Sugimura T, Birnbaum SM, Winitz M, Greenstein JP. Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. Arch Biochem Biophys. 1959;81(2):448–455. doi: 10.1016/0003-9861(59)90225-5. [DOI] [PubMed] [Google Scholar]
  • 20.Otsuka K, Yamamoto Y, Ochiya T. Uncovering temperature-dependent extracellular vesicle secretion in breast cancer. J Extracell Vesicles. 2020;10(2):e12049. doi: 10.1002/jev2.12049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Inubushi S, Kawaguchi H, Mizumoto S, Kunihisa T, Baba M, Kitayama Y, Takeuchi T, Hoffman RM, Tanino H, Sasaki R. Oncogenic miRNAs identified in tear exosomes from metastatic breast cancer patients. Anticancer Res. 2020;40(6):3091–3096. doi: 10.21873/anticanres.14290. [DOI] [PubMed] [Google Scholar]
  • 22.Kaiser P. Methionine dependence of cancer. Biomolecules. 2020;10(4):568. doi: 10.3390/biom10040568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chello PL, Bertino JR. Dependence of 5-methyltetrahydrofolate utilization by L5178Y murine leukemia cells in vitro on the presence of hydroxycobalamin and transcobalamin II. Cancer Res. 1973;33(8):1898–1904. [PubMed] [Google Scholar]
  • 24.Halpern BC, Clark BR, Hardy DN, Halpern RM, Smith RA. The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci USA. 1974;71(4):1133–1136. doi: 10.1073/pnas.71.4.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ashe H, Clark BR, Chu F, Hardy DN, Halpern BC, Halpern RM, Smith RA. N5-methyltetrahydrofolate: Homocysteine methyl transferase activity in extracts from normal, malignant and embryonic tissue culture cells. Biochem Biophys Res Commun. 1974;57(2):417–425. doi: 10.1016/0006-291x(74)90947-4. [DOI] [PubMed] [Google Scholar]
  • 26.Sullivan MR, Darnell AM, Reilly MF, Kunchok T, Joesch-cohen L, Rosenberg D, Ali A, Rees MG, Roth JA, Lewis CA, Vander Heiden MG. Methionine synthase is essential for cancer cell proliferation in physiological folate environments. Nat Metab. 2021;3(11):1500–1511. doi: 10.1038/s42255-021-00486-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yamamoto J, Inubushi S, Han Q, Tashiro Y, Sugisawa N, Hamada K, Aoki Y, Miyake K, Matsuyama R, Bouvet M, Clarke SG, Endo I, Hoffman RM. Linkage of methionine addiction, histone lysine hypermethylation, and malignancy. iScience. 2022;25(4):104162. doi: 10.1016/j.isci.2022.104162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yamamoto J, Han Q, Simon M, Thomas D, Hoffman RM. Methionine Restriction: Ready for Prime Time in the Cancer Clinic. Anticancer Res. 2022;42(2):641–644. doi: 10.21873/anticanres.15521. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Genomics & Proteomics are provided here courtesy of International Institute of Anticancer Research

RESOURCES